share_log

Wells Fargo Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $47

Wells Fargo Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $47

富国银行维持对PROCEPT BioRobotics的增持,将目标股价上调至47美元
Benzinga ·  01/09 08:38

Wells Fargo analyst Nathan Treybeck maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price target from $44 to $47.

富国银行分析师内森·特雷贝克维持PROCEPT BioRobotics(纳斯达克股票代码:PRCT)增持,并将目标股价从44美元上调至47美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发